Increase/Decrease in Cash: The total change in cash for the company over the given period.
IMMURON (IMRN) had Increase/Decrease in Cash of $-5.72M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$6.46M |
|
-- |
|
$0.00M |
|
$6.54M |
|
$1.27M |
|
-- |
|
$0.06M |
|
$1.33M |
|
$5.20M |
|
$5.20M |
|
$5.20M |
|
-- |
|
| Cash Flow Statement Financials | |
$-3.97M |
|
$-1.88M |
|
$0.13M |
|
$7.55M |
|
$1.83M |
|
|
Increase/Decrease in Cash |
$-5.72M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|